Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane.
There is increasing evidence that locally produced angiotensin AII (AII) regulates the function of many tissues, but the involvement of enterocyte-derived AII in the control of intestinal transport is unknown. This study examined whether there is a local renin-angiotensin system (RAS) in rat villus enterocytes and assessed the effects of AII on SGLT1-dependent glucose transport across the brush border membrane (BBM). Gene and protein expression of angiotensinogen, ACE, and AT(1) and AT(2) receptors were studied in jejunal and ileal enterocytes using immunocytochemistry, Western blotting and RT-PCR. Mucosal uptake of d-[(14)C]glucose by everted intestinal sleeves before and after addition of AII (0-100 nm) to the mucosal buffer was measured in the presence or absence of the AT(1) receptor antagonist losartan (1 microm). Immunocytochemistry revealed the expression of angiotensinogen, ACE, and AT(1) and AT(2) receptors in enterocytes; immunoreactivity of AT(1) receptor and angiotensinogen proteins was especially pronounced at the BBM. Expression of angiotensinogen and AT(1) and AT(2) receptors, but not ACE, was greater in the ileum than the jejunum. Addition of AII to mucosal buffer inhibited phlorizin-sensitive (SGLT1-dependent) jejunal glucose uptake in a rapid and dose-dependent manner and reduced the expression of SGLT1 at the BBM. Losartan attenuated the inhibitory action of AII on glucose uptake. AII did not affect jejunal uptake of l-leucine. The detection of RAS components at the enterocyte BBM, and the rapid inhibition of SGLT1-dependent glucose uptake by luminal AII suggest that AII secretion exerts autocrine control of intestinal glucose transport.
Wong
Tung Po
TP
Department of Physiology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.
Debnam
Edward S
ES
Leung
Po Sing
PS
D000804:Angiotensin II / Q000378:metabolism*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000808:Angiotensinogen / Q000235:genetics / Q000378:metabolism; D000818:Animals; D019898:Autocrine Communication; D015153:Blotting, Western; D020895:Enterocytes / Q000187:drug effects / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D007082:Ileum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D007583:Jejunum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007930:Leucine / Q000378:metabolism; D019808:Losartan / Q000494:pharmacology; D008297:Male; D008871:Microvilli / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000235:genetics / Q000378:metabolism; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000235:genetics / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000235:genetics; D051269:Sodium-Glucose Transporter 1 / Q000378:metabolism*
D047228:Angiotensin II Type 1 Receptor Blockers; D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; C495676:Slc5a1 protein, rat; D051269:Sodium-Glucose Transporter 1; D000808:Angiotensinogen; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; D007930:Leucine; D005947:Glucose; D019808:Losartan
Exp Physiol. 1994 Mar;79(2):203-14
8003304
Am J Physiol. 1993 Jul;265(1 Pt 1):G21-7
8338170
Kidney Int. 1994 Dec;46(6):1603-10
7700017
Pflugers Arch. 1995 Jun;430(2):151-9
7675626
Am J Physiol. 1996 Sep;271(3 Pt 1):G477-82
8843773
J Anim Sci. 1996 Oct;74(10):2523-40
8904722
Gut. 1996 Oct;39(4):545-50
8944563
J Exp Biol. 1997 Jan;200(Pt 2):287-93
9050236
Am J Physiol. 1997 Dec;273(6 Pt 2):R1965-71
9435650
J Biol Chem. 1998 Jun 5;273(23):14545-9
9603969
Am J Physiol. 1998 Aug;275(2 Pt 2):R515-23
9688688
Eur J Clin Invest. 1998 Aug;28(8):651-8
9767360
Gastroenterology. 1998 Nov;115(5):1163-71
9797371
Gut. 1999 Apr;44(4):490-6
10075955
Diabetes. 2005 Feb;54(2):348-54
15677491
Am J Physiol Gastrointest Liver Physiol. 2005 Dec;289(6):G1007-14
16020657
Physiol Rev. 2006 Jul;86(3):747-803
16816138
J Physiol. 2007 Apr 1;580(Pt 1):31-7
17218353
Antioxid Redox Signal. 2007 Jul;9(7):869-78
17508912
Acta Physiol (Oxf). 2007 Aug;190(4):303-10
17488247
Biochim Biophys Acta. 1978 Jan 4;506(1):136-54
620021
Gut. 2000 Aug;47(2):184-91
10896908
Mol Cell Endocrinol. 2000 Aug 30;166(2):121-8
10996430
J Physiol. 2001 Mar 15;531(Pt 3):585-95
11251042
Biochim Biophys Acta. 2002 Feb 15;1559(2):179-85
11853684
Gut. 2002 Jun;50(6):797-802
12010881
Life Sci. 2002 May 24;71(1):1-13
12020744
J Hypertens. 2003 Feb;21(2):353-60
12569266
Eur J Biochem. 2003 Aug;270(16):3377-88
12899695
Regul Pept. 2003 Nov 15;116(1-3):61-9
14599716
J Mol Endocrinol. 2003 Dec;31(3):563-71
14664716
Diabetologia. 2004 Feb;47(2):240-8
14722647
Am J Physiol Renal Physiol. 2004 Apr;286(4):F634-42
14644748
Biochem Biophys Res Commun. 2004 May 7;317(3):717-21
15081399
Curr Protein Pept Sci. 2004 Aug;5(4):267-73
15320733
J Biol Chem. 1974 Jan 25;249(2):664-6
4358562
Anal Biochem. 1976 May 7;72:248-54
942051
Br J Pharmacol. 1986 Jan;87(1):201-9
2869810
Biochim Biophys Acta. 1986 Aug 21;860(2):277-85
3741853
Am J Physiol. 1987 Jul;253(1 Pt 1):G54-61
3605337
Biochim Biophys Acta. 1987 Jul 23;901(2):201-8
3607046
Am J Physiol. 1987 Dec;253(6 Pt 1):G781-6
2827504
Gastroenterology. 1988 Apr;94(4):942-7
2831105
J Physiol. 1988 Mar;397:503-12
3411516
Am J Physiol. 1990 Nov;259(5 Pt 1):G822-37
2240224
Am J Physiol. 1991 Mar;260(3 Pt 1):G440-9
1848409
Biochim Biophys Acta. 1991 Dec 2;1129(1):87-9
1836740
Biochem J. 1992 Sep 1;286 ( Pt 2):451-7
1326943
Am J Physiol. 1992 Oct;263(4 Pt 1):G466-73
1329552
Exp Physiol. 1993 Mar;78(2):197-207
8471240
J Physiol. 1994 Jul 15;478 ( Pt 2):187-93
7965840